Antipsychotic Agents - Research News and Information

Thursday, January 08, 2009

Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

6 Oct 2008 Recent studies suggest that subtype-selective activators of M(1)/M(4) muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms associated with schizophrenia and Alzheimer's disease. Previously ... Read more...

Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.

Oct 2008 AIM: To examine a New Zealand case series of clozapine-associated myocarditis. METHODS: All cases of myocarditis in the Intensive Medicines Monitoring Programme's (IMMP) clozapine database were identified and reviewed. RESULTS: 25 cases of ... Read more...

Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action.

29 Sep 2008 BACKGROUND: Antipsychotic drugs are the most effective treatment for the psychotic symptoms of schizophrenia, yet their mechanism of action remains largely unknown. OBJECTIVES: Earlier studies have shown gene expression changes in rodent brains ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Antipsychotic Agents'

These are the very latest articles for this heading:

• New findings on antipsychotic use in children and adolescents with schizophrenia spectrum disorders. 30 Oct 2008
• What explains the diffusion of treatments for mental illness? 30 Oct 2008
• Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine. 30 Oct 2008
• Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. 6 Oct 2008
• Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme. Oct 2008
• Olanzapine-induced rabbit syndrome. 29 Sep 2008
• A clinical paradigm of delusions of parasitosis. 29 Sep 2008
• Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action. 29 Sep 2008
• Acute effects of newer antipsychotic drugs on glucose metabolism. 29 Sep 2008
• American Chemical Society--236th National Meeting & Exposition. Compound development for prevalent conditions. 29 Sep 2008
• British Association for Psychopharmacology--2008 Summer Meeting. 29 Sep 2008
• The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients. 29 Sep 2008
• Bipolar drug development: are we getting closer to the real world? 29 Sep 2008
• Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. 29 Sep 2008
• Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. 29 Sep 2008
• [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?] 28 Sep 2008
• Antipsychotics and stroke risk. Madness of modern medicine. 14 Sep 2008
• Effect of antipsychotics on stroke risk remains unproved. 14 Sep 2008
• [Olanzapine] 14 Sep 2008
• Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. 13 Sep 2008

See a longer list of these articles.

Technical information about 'Antipsychotic Agents'

Definition: Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in schizophrenia, senile dementia, transient psychosis following surgery or myocardial infarction, etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Registry Number: 0

Descriptor UI: D014150

Alternative terms: Antipsychotic Agents; Agents, Antipsychotic; Tranquilizing Agents, Major; Agents, Major Tranquilizing; Major Tranquilizing Agents; Tranquillizing Agents, Major; Agents, Major Tranquillizing; Major Tranquillizing Agents; Major Tranquilizers; Tranquilizers, Major; Antipsychotics; Antipsychotic Drugs; Drugs, Antipsychotic; Neuroleptic Drugs; Drugs, Neuroleptic; Neuroleptics; Neuroleptic Agents; Agents, Neuroleptic;

Related Mesh Headings: Dopamine Antagonists;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.277.950.040; D27.505.954.427.210.950.040; D27.505.954.427.700.872.331;

Online Note: use ANTIPSYCHOTIC AGENTS to search TRANQUILIZING AGENTS, MAJOR 1975-94; use TRANQUILIZING AGENTS to search NEUROLEPTICS 1969-94

History Note: 95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74

Technical Notes: GEN or unspecified; prefer specific groups or specific drugs; consider also PSYCHOSES /drug ther